News | Contrast Media Injectors | June 29, 2020

Guerbet Segments Consumables in Two Essential and Excellence Ranges

Guerbet shows its commitment to healthcare professionals with two ranges of consumables selected for their injection solutions

Guerbet shows its commitment to healthcare professionals with two ranges of consumables selected for their injection solutions

June 29, 2020 — Guerbet has launched a new "consumables.guerbet.com" website presenting its Essential and Excellence ranges of consumables for use with injection solutions and tailored for diagnostic imaging professionals.

Essential certified by Guerbet is a range of easy-to-use consumables certified by Guerbet and supplied by manufacturers selected by the company. They are all tested and approved according to Guerbet quality standards and comply with medical devices regulations. 

Excellence designed by Guerbet is a range of consumables designed from Guerbet research offering innovative1 safety features and improving the workflow of injection procedures.

"We have segmented our consumables in two clearly identified Essential and Excellence ranges to make it easier for healthcare professionals to reach decisions. All our consumables are compatible with our CT, Cath Lab and MRI injection systems and benefit from our commitment to delivering safe, high-quality solutions crucial for improving patient prognosis and quality of life," said Valérie Brissart, Global Marketing Director of CT and Cath Lab Imaging Solutions at Guerbet.

Both ranges of consumables offer syringes and kits, patient lines, day-sets, tubing and accessories for each of the Guerbet power injectors: OptiVantage Multi-use, OptiVantage Single-use, Illumena Néo, FlowSens, OptiStar Elite, OptiOne.

For more information: consumables.guerbet.com

 

1Vermeulen C, Noury B & Al. - Microbial Safety Assessment of a Double Check-Valve Patient Line in a Multi-use Contrast Delivery System Radiol Technol. 2015 Nov-Dec;87(2):139-49

Related Content

Steinberg Diagnostic Medical Imaging headquarters.

Steinberg Diagnostic Medical Imaging headquarters.

Sponsored Content | Case Study | Contrast Media Injectors | January 21, 2021
Steinberg Diagnostic Medical Imaging (SDMI) was founded 30 years a
According to a new research report1 on the contrast media injectors published by MarketsandMarkets, the market was estimated to be $1.3 billion in 2020 and projected to reach $1.9 billion by 2025, at a compound annual growth rate (CAGR) of 7.4 percent over 2020-2025.

The ulrich CTmotion

Feature | Contrast Media Injectors | January 20, 2021 | By Melinda Taschetta-Millane
According to a new...
This novel agent, based on the essential nutrient manganese, has strong potential as a safer alternative to currently used contrast agents
News | Contrast Media | December 28, 2020
December 28, 2020 — Adding a contrast-enhancing agent to...
Bayer Radiology is announcing Radimetrics v3.0, the newest evolution of its enterprise dose management application.
News | Radiation Dose Management | December 11, 2020
December 11, 2020 — Bayer Radiology is announcing Radimetrics v3.0, the newest evolution of its enterprise dose manag
Bracco Diagnostics Inc. announced it will be showcasing its full portfolio of diagnostic imaging solutions in an immersive digital experience at the first all-virtual Radiological Society of North America (RSNA) annual meeting being held November 29 through December 5.
News | Contrast Media Injectors | November 17, 2020
November 17, 2020 — Bracco Diagnostics Inc.
Guerbet announced that it will highlight UNIK, a tailored solution for diagnostic imaging, at the 2020 annual meeting of the Radiological Society of North America (RSNA).
News | Contrast Media | November 17, 2020
November 17, 2020 — Guerbet announced that it will highlight UNIK, a tailored solution for diagnostic imaging, at the
This study found cardiac MRI gadolinium-based contrast agents are safe for patient use. Overall, there were only 556 acute adverse effects in 145,855 contrast-enhanced MRIs, with only 47 being classified as severe. 

This study found cardiac MRI gadolinium-based contrast agents are safe for patient use. Overall, there were only 556 acute adverse effects in 145,855 contrast-enhanced MRIs, with only 47 being classified as severe. 

Feature | Magnetic Resonance Imaging (MRI) | October 29, 2020
October 29, 2020 — Contrast agents used to improve views of the heart on magnetic resonance imaging (MRI) carry a ver
the Contrast Media Injectors Market is estimated to be USD 1.3 billion in 2020 and  projected to reach $1.9B by 2025, at a CAGR of 7.4% between 2020 and 2025

Getty Images

News | Contrast Media Injectors | September 02, 2020
September 2, 2020 — According to the new market research report "...